Cargando…

Genetic Abnormalities in Chronic Lymphocytic Leukemia: Where We Are and Where We Go

Chromosomal abnormalities in chronic lymphocytic leukemia (CLL) are detected in up to 80% of patients. Among them, deletions of 11q, 13q, 17p, and trisomy 12 have a known prognostic value and play an important role in CLL pathogenesis and evolution, determining patients outcome and therapeutic strat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puiggros, Anna, Blanco, Gonzalo, Espinet, Blanca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4054680/ https://www.ncbi.nlm.nih.gov/pubmed/24967369 http://dx.doi.org/10.1155/2014/435983

Ejemplares similares

Chronic Pulmonary Aspergillosis—Where Are We? and Where Are We Going?
por: Hayes, Gemma E., et al.
Publicado: (2016)

Bioactive Glasses: Where Are We and Where Are We Going?
por: Baino, Francesco, et al.
Publicado: (2018)

Diabetic cardiomyopathy: where we are and where we are going
por: Lee, Wang-Soo, et al.
Publicado: (2017)

Hidradenitis Suppurativa: Where We Are and Where We Are Going
por: Scala, Emanuele, et al.
Publicado: (2021)

Obstetric ultrasound: where are we and where are we going?
por: Abramowicz, Jacques S
Publicado: (2021)

Colon Capsule Endoscopy: Where Are We and Where Are We Going
por: Han, Yoo Min, et al.
Publicado: (2016)

Accommodative intraocular lenses: where are we and where we are going
por: Alió, Jorge L., et al.
Publicado: (2017)

Osteoarthritis and Diabetes: Where Are We and Where Should We Go?
por: Alenazi, Aqeel M., et al.
Publicado: (2023)

Biomarkers of Neonatal Sepsis: Where We Are and Where We Are Going
por: Boscarino, Giovanni, et al.
Publicado: (2023)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Craniofacial genetics: Where have we been and where are we going?
por: Weinberg, Seth M., et al.
Publicado: (2018)

Critical care - where have we been and where are we going?
por: Vincent, Jean-Louis
Publicado: (2013)

Male contraception: where are we going and where have we been?
por: Reynolds-Wright, John Joseph, et al.
Publicado: (2019)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)

Artificial Intelligence in Digestive Endoscopy—Where Are We and Where Are We Going?
por: Vulpoi, Radu-Alexandru, et al.
Publicado: (2022)

Alopecia Areata in Latin America: Where are We and Where are We Going?
por: Velásquez-Lopera, Margarita M., et al.
Publicado: (2022)

The peritumoral brain zone in glioblastoma: where we are and where we are going
por: Giambra, Martina, et al.
Publicado: (2022)

The Clusmy Child: Where Are We and Where Are We Going?
por: Hadders-Algra, Mijna, et al.
Publicado: (2003)

European HEPnet: where we are and where we are going
por: Carpenter, B E, et al.
Publicado: (1990)

Iron health: where are we and where are we going?
por: Gotardo, Glória Ines Beal
Publicado: (2011)

Hip Arthroscopy: Where We Are, and Where We Are Going
por: Park, Myung Sik, et al.
Publicado: (2015)

Where We Are and Where We Are Going in Nut Research
por: Salas-Salvadó, Jordi, et al.
Publicado: (2023)

COVID-19: Where We Are and Where We Are Going
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Telemedicine in ophthalmology - where are we and where are we going?
por: Pîrvulescu, Ruxandra
Publicado: (2023)

Therapeutic options for lymphangioleiomyomatosis (LAM): where we are and where we are going
por: Taveira-DaSilva, Angelo M, et al.
Publicado: (2009)

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

Acute childhood leukemia in India: Where are we going, where have we been?
por: Kanwar, Vikramjit Singh
Publicado: (2016)

Treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Where Do We Stand? Where Do We Go?
por: Eichenauer, Dennis A., et al.
Publicado: (2023)

Where are we coming from? What are we? Where are we going?
por: Ellis, John R.
Publicado: (1995)

The living universe: where are we? who are we? where are we going?
por: Elgin, Duane, et al.
Publicado: (2009)

Anticipation in Lynch Syndrome: Where We Are Where We Go
por: Bozzao, Cristina, et al.
Publicado: (2011)

Global Mental Health: Where We Are and Where We Are Going
por: Moitra, Modhurima, et al.
Publicado: (2023)

Where are we going?
por: Pawl, Ronald P.
Publicado: (2010)

Pim kinases in hematological malignancies: where are we now and where are we going?
por: Mondello, Patrizia, et al.
Publicado: (2014)

Research on Service-Learning in Physical Activity and Sport: Where We Have Been, Where We Are, Where We Are Going
por: Francisco-Garcés, Xavier, et al.
Publicado: (2022)

Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?
por: Ottenhoff, Tom H. M., et al.
Publicado: (2012)

Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go
por: Buchsbaum, Rachel J., et al.
Publicado: (2016)

Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?
por: Turnbull, Samantha, et al.
Publicado: (2015)

Cytokine removal in human septic shock: Where are we and where are we going?
por: Honore, Patrick M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_56qvpbjdcn8bp4fnu8vtpltlp1